To Evaluate the Therapeutic Equivalence and Safety in Treatment of Scalp Psoriasis

NCT03880357 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

485

Enrollment

INDUSTRY

Sponsor class

Conditions

Scalp Psoriasis

Interventions

DRUG: Betamethasone Scalp Suspension 0.064%;0.0005%
DRUG: Taclonex®
DRUG: Placebo topical suspension

Sponsor

Sun Pharmaceutical Industries, Inc.